Dana Lapointe-hymel, CRNA | |
1214 Coolidge Blvd, Lafayette, LA 70503-2621 | |
(504) 779-5515 | |
Not Available |
Full Name | Dana Lapointe-hymel |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 23 Years |
Location | 1214 Coolidge Blvd, Lafayette, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114968922 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | RN08139 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Park Place Surgical Hospital | Lafayette, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Anesthesiology And Pain Consultants Llc | 3870490402 | 48 |
News Archive
DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).
"Medical breakthroughs are often based on collaborative work between departments, or the sharing of knowledge and expertise across the sciences - for instance in the development of MRI scanners. If science department closures continue, research and development in medicine will be under threat."
Scientists helping to develop the next generation of cancer-beating drugs say they have had a major breakthrough with their latest results.
Loyola University Chicago Health Sciences students, faculty and staff will participate in simulations to help them better understand what it is like to live in poverty.
Paracetamol is no more effective than placebo at relieving acute lower back pain, according to new clinical trial results.
› Verified 4 days ago
Entity Name | Anesthesiology & Pain Consultants Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841287901 PECOS PAC ID: 3870490402 Enrollment ID: O20031212000737 |
News Archive
DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).
"Medical breakthroughs are often based on collaborative work between departments, or the sharing of knowledge and expertise across the sciences - for instance in the development of MRI scanners. If science department closures continue, research and development in medicine will be under threat."
Scientists helping to develop the next generation of cancer-beating drugs say they have had a major breakthrough with their latest results.
Loyola University Chicago Health Sciences students, faculty and staff will participate in simulations to help them better understand what it is like to live in poverty.
Paracetamol is no more effective than placebo at relieving acute lower back pain, according to new clinical trial results.
› Verified 4 days ago
Entity Name | Youngs Professional Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20070226000608 |
News Archive
DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).
"Medical breakthroughs are often based on collaborative work between departments, or the sharing of knowledge and expertise across the sciences - for instance in the development of MRI scanners. If science department closures continue, research and development in medicine will be under threat."
Scientists helping to develop the next generation of cancer-beating drugs say they have had a major breakthrough with their latest results.
Loyola University Chicago Health Sciences students, faculty and staff will participate in simulations to help them better understand what it is like to live in poverty.
Paracetamol is no more effective than placebo at relieving acute lower back pain, according to new clinical trial results.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dana Lapointe-hymel, CRNA 255 W Michigan Ave, Jackson, MI 49201-2218 Ph: (517) 787-6440 | Dana Lapointe-hymel, CRNA 1214 Coolidge Blvd, Lafayette, LA 70503-2621 Ph: (504) 779-5515 |
News Archive
DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).
"Medical breakthroughs are often based on collaborative work between departments, or the sharing of knowledge and expertise across the sciences - for instance in the development of MRI scanners. If science department closures continue, research and development in medicine will be under threat."
Scientists helping to develop the next generation of cancer-beating drugs say they have had a major breakthrough with their latest results.
Loyola University Chicago Health Sciences students, faculty and staff will participate in simulations to help them better understand what it is like to live in poverty.
Paracetamol is no more effective than placebo at relieving acute lower back pain, according to new clinical trial results.
› Verified 4 days ago
Charles L. Papadakes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-988-4298 | |
Mr. Stephen Kyle Chauvin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 314 Youngsville Hwy, Lafayette, LA 70508 Phone: 337-706-1500 | |
Brittany Dibetta Belk, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 215 Republic Ave, Apt 6105, Lafayette, LA 70508 Phone: 504-451-4464 | |
Paula L. Simon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4200 W Congress St, Suite 3200, Lafayette, LA 70506 Phone: 337-981-3546 | |
Mr. Bowen J Landry, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Saint Landry St, Lafayette, LA 70506 Phone: 337-289-2966 Fax: 337-289-2776 | |
Dexter Paul Guidry Ii, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4212 W Congress St, Suite 3200, Lafayette, LA 70506 Phone: 337-981-3546 Fax: 337-988-4298 | |
Mr. Jude L Guillory, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1103 Kaliste Saloom Rd, Suite 304, Lafayette, LA 70508 Phone: 337-988-5646 Fax: 337-988-4298 |